Invention Grant
- Patent Title: Medicament for treatment of diabetic foot infections
-
Application No.: US16079804Application Date: 2017-02-27
-
Publication No.: US10751351B2Publication Date: 2020-08-25
- Inventor: Grégoire Vuagniaux , Linda Kadi , Frederick Wittke
- Applicant: Debiopharm International S.A.
- Applicant Address: CH Lausanne
- Assignee: Debiopharm International S.A.
- Current Assignee: Debiopharm International S.A.
- Current Assignee Address: CH Lausanne
- Agency: Wolf, Greenfield & Sacks, P.C.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@46e7ba79 com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@68165350
- International Application: PCT/EP2017/054470 WO 20170227
- International Announcement: WO2017/144717 WO 20170831
- Main IPC: A61K31/675
- IPC: A61K31/675 ; A61K31/4375 ; A61P31/04 ; A61K9/00
Abstract:
The present invention provides means and methods for treating diabetic foot infections. In particular, drug compounds are provided that combine a high therapeutic activity against Staphylococcus Spp. bacteria with a high degree of bone penetration and vasodilatory effects. This unique combination of properties allows to accomplish high local concentrations of the drug at the site of infection even in diabetic foot patients typically having poor blood perfusion at the site of infection.
Public/Granted literature
- US20190054100A1 MEDICAMENT FOR TREATMENT OF DIABETIC FOOT INFECTIONS Public/Granted day:2019-02-21
Information query
